Clinical Trials Browser

Recurrence × Trastuzumab × Other hematologic neoplasm × Clear all

NCT00724360 2013-10-07

Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL)

Phase 2 Terminated

Other hematologic neoplasm

Leukemia, Recurrence